COVID-19 patients often show high-titer non-platelet-activating anti-PF4/heparin IgG antibodies - Brodard, J; Kremer Hovinga, J A; Fontana, P; Studt, J D; Gruel, Y; Greinacher, A (J Thromb Haemost, 2021)